US equities
|
NVDA
$214.25
▼-3.19%
MU
$859.58
▼-5.97%
SNDK
$1,277.00
▼-9.00%
SPCX
$143.35
▼-5.79%
AMD
$534.39
▼-6.38%
TSM
$411.38
▼-4.33%
INTC
$92.45
▼-5.78%
AAPL
$346.05
▲+0.90%
NVDA
$214.25
▼-3.19%
MU
$859.58
▼-5.97%
SNDK
$1,277.00
▼-9.00%
SPCX
$143.35
▼-5.79%
AMD
$534.39
▼-6.38%
TSM
$411.38
▼-4.33%
INTC
$92.45
▼-5.78%
AAPL
$346.05
▲+0.90%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Cardiol Therapeutics Inc. - Class A Common Shares
(NQ:
CRDL
)
1.140
UNCHANGED
Delayed Quote
Updated: 9:38 AM EDT, Oct 15, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Cardiol Therapeutics Inc. - Class A Common Shares
< Previous
1
2
Next >
Cardiol Therapeutics Advances CardiolRx in Pivotal Phase III Pericarditis Trial
↗
August 12, 2026
Cardiol Therapeutics (NASDAQ:CRDL) is advancing its synthetic, pharmaceutical-grade cannabidiol formulation, CardiolRx, in a pivotal Phase III trial for recurrent pericarditis, with management...
Via
MarketBeat
On Tuesday, there are stocks with unusual volume. Let's take a look.
↗
March 31, 2026
Via
Chartmill
This Visa Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday
↗
June 02, 2025
Via
Benzinga
3 Penny Stocks Ready to Break Out in 2025
November 29, 2024
Vuzix, GeoVox Labs, and Cardiol Therapeutics emerged as notable penny stocks late in 2024 for their potential to scale operations and launch new products.
Via
MarketBeat
Why Cardiol Therapeutics (CRDL) Stock Is Down 20% Today
↗
October 09, 2024
Cardiol Therapeutics shares are trading lower by 20% Wednesday morning. The company announced a $13.5 million public offering.
Via
Benzinga
Stocks That Hit 52-Week Lows On Wednesday
↗
October 19, 2022
On Wednesday, 200 companies hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
↗
March 11, 2022
During Friday's session, 198 companies made new 52-week lows. Key Facts About Today's 52-Week Highs And Lows: Alibaba Group Holding (NYSE:BABA) is the largest...
Via
Benzinga
CBD-Based Drug Reduces Pericarditis Pain And Inflammation, Shows New Clinical Study
↗
November 19, 2024
Via
Benzinga
AZZ, Helen of Troy And 3 Stocks To Watch Heading Into Wednesday
↗
October 09, 2024
Via
Benzinga
CRDL Stock Earnings: Cardiol Therapeutics Beats EPS for Q2 2024
↗
August 12, 2024
CRDL stock results show that Cardiol Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
Via
InvestorPlace
Hope on the Horizon: Results from MAvERIC-Pilot Show Heartfelt Progress for Patients
June 17, 2024
Hope on the Horizon: Results from MAvERIC-Pilot Show Heartfelt Progress for Patients
Via
News Direct
Analysts’ Consensus Reaffirms Significant Upside Potential for Cardiol Therapeutics
May 28, 2024
Analysts’ Consensus Reaffirms Significant Upside Potential for Cardiol Therapeutics
Via
News Direct
CRDL Stock Earnings: Cardiol Therapeutics Meets EPS for Q1 2024
↗
May 14, 2024
CRDL stock results show that Cardiol Therapeutics met analyst estimates for earnings per share the first quarter of 2024.
Via
InvestorPlace
Will Pharma And Healthcare Have Competitive Edge In Cannabis Post-Rescheduling? Data Analytics Expert Weighs In
↗
May 14, 2024
Roy Bingham, CEO of BDSA, anticipates substantial growth in the U.S. cannabis market, projecting sales to reach nearly $46 billion by 2028.
Via
Benzinga
Topics
Cannabis
CRDL Stock Earnings: Cardiol Therapeutics Beats EPS for Q4 2023
↗
April 02, 2024
CRDL stock results show that Cardiol Therapeutics beat analyst estimates for earnings per share the fourth quarter of 2023.
Via
InvestorPlace
Cardiol Therapeutics - This Penny Stock Is An Analysts Favorite
↗
January 31, 2024
Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies.
Via
Talk Markets
Cardiol Therapeutics (NASDAQ: CRDL) Advancements in Therapies for Inflammatory Heart Diseases
October 13, 2023
--News Direct--
Via
News Direct
Topics
Death
Cardiol Therapeutics Fights Heart Inflammation With Novel Formulations
↗
October 12, 2023
697,000 people die from heart disease every year in the United States – that is one in every five deaths.
Via
Benzinga
CBD To Treat Heart Failure? New Study Shows Its Cardioprotective Effects
↗
October 10, 2023
On Tuesday, Cardiol Therapeutics Inc. (NASDAQ: CRDL) (TSX: CRDL) announced positive study results demonstrating that subcutaneously administered cannabidiol - the active pharmaceutical ingredient in...
Via
Benzinga
Why Murphy Canyon Acquisition Shares Are Trading Higher By Around 32%; Here Are 20 Stocks Moving Premarket
↗
September 21, 2023
Gainers Near Intelligence, Inc. (NASDAQ: NIR) shares rose 34.1% to $0.2801 in pre-market trading after falling 42% on Wednesday. Near Intelligence recently named its General Counsel, Jay Angelo, to...
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
October 04, 2022
On Tuesday, 44 companies hit new 52-week lows.
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
↗
October 18, 2022
During Tuesday's session, 78 companies made new 52-week lows.
Via
Benzinga
FDA Clears Cardiol Therapeutics' IND for CardiolRx in Recurrent Pericarditis
↗
May 17, 2022
The U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug Application (IND) from Cardiol Therapeutics Inc. (NASDAQ: CRDL) to start a Phase 2 open-label pilot study designed...
Via
Benzinga
76 Biggest Movers From Yesterday
↗
May 19, 2022
Gainers Bright Green Corp. (NASDAQ: BGXX) jumped 90.5% to close at $48.08 on Wednesday. Bright Green Corporation, went public on the NASDAQ Tuesday, becoming the first U.S. plant-touching company to...
Via
Benzinga
34 Stocks Moving In Monday's Mid-Day Session
↗
April 18, 2022
Gainers Casa Systems, Inc. (NASDAQ: CASA) shares climbed 66.3% to $6.47 after the company announced a multi-year contract with Verizon to provide 5G core network functions....
Via
Benzinga
68 Biggest Movers From Yesterday
↗
April 19, 2022
Gainers Casa Systems, Inc. (NASDAQ: CASA) shares surged 82.5% to close at $7.10 on Monday after the company announced a multi-year contract with Verizon to provide 5G core...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 17, 2022
↗
March 17, 2022
Upgrades Loop Capital upgraded the previous rating for Aspen Technology Inc (NASDAQ:AZPN) from Hold to Buy. In the second quarter, Aspen Technology showed an EPS of $1.20,...
Via
Benzinga
51 Biggest Movers From Thursday
↗
April 18, 2022
Gainers MedAvail Holdings, Inc. (NASDAQ: MDVL) shares surged 69.4% to close at $2.44 on Thursday. Ally Bridge Group recently reported a purchase of 21.176 million shares of...
Via
Benzinga
Cardiol Therapeutics To Include Vaccinated Participants In Cannabidiol COVID-19 Trial
↗
March 01, 2022
The FDA and regulatory agencies in Brazil & Mexico have cleared Cardiol Therapeutics Inc (NASDAQ: CRDL) to modify the inclusion criteria for the LANCER trial to...
Via
Benzinga
52 Biggest Movers From Yesterday
↗
January 20, 2022
Gainers Zogenix, Inc. (NASDAQ: ZGNX) shares surged 65.7% to close at $25.92 on Wednesday after the company announced it will be acquired by UCB for approximately $1.9 billion. G...
Via
Benzinga
< Previous
1
2
Next >
